Hi Reg,
absolutely right about MSB's RMAT for back pain being unique.
And its not just Athersys that's not doing so well in using its RMAT - Vericel's web site is dead cold - their autologous product's not even in their pipeline. Check it out:
The cloud has parted & it looks like we're flying alone in these skies Reg. Not a bad feeling.
Cheers
PS: I was working off the FDA's own list of granted/ refused/ withdrawns to come up with 101 as of December last - link https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/cumulative-cber-regenerative-medicine-advanced-therapy-rmat-designation-requests-received-fiscal . But some of those could have been handed back (unlikely), and some could be flying under the radar. Or their sponsors are pining for the fjords. It's tough in biotech.
Cheers
GLTA(LT)H
Hi Reg, absolutely right about MSB's RMAT for back pain being...
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.14 |
Change
-0.040(3.39%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.18 | $1.13 | $2.135M | 1.861M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 3386 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.15 | 33039 | 13 |
View Market Depth
| Last trade - 11.27am 17/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |